VAXCYTE INC. - COMMON STOCK

Vaxcyte Reports First Quarter 2021 Financial Results and Provides Business Update

11 май 2021 15:10:00 Источник Nasdaq GlobeNewswire

Vaxcyte Announces Publication of Preclinical Data Supporting the Potential of VAX-24 for the Prevention of Invasive Pneumococcal Disease

10 май 2021 07:30:00 Источник Nasdaq GlobeNewswire

Vaxcyte to Present at BofA Securities 2021 Health Care Conference

06 май 2021 15:05:02 Источник Nasdaq GlobeNewswire

Vaxcyte to Present at 20th Annual Needham Virtual Healthcare Conference

05 апр 2021 15:30:00 Источник Nasdaq GlobeNewswire

Vaxcyte Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

29 мар 2021 15:10:00 Источник Nasdaq GlobeNewswire

Vaxcyte to Report Fourth Quarter and Full Year 2020 Financial Results on March 29, 2021

22 мар 2021 15:05:00 Источник Nasdaq GlobeNewswire

Vaxcyte Announces Publication of Preclinical Proof-of-Concept Data Supporting Potential of VAX-A1, a Novel Conjugate Vaccine Designed to Prevent Group A Strep Infections

06 янв 2021 07:15:00 Источник Nasdaq GlobeNewswire